| Benjamin Dental Group | |
|
60 Union St Sidney NY 13838-1430 | |
| (607) 563-2333 | |
| Not Available |
| Full Name | Benjamin Dental Group |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 60 Union St, Sidney, New York |
| Authorized Official Name and Position | Scott D Benjamin (PRESIDENT) |
| Authorized Official Contact | 6075632333 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Dental Group Po Box 27 Sidney NY 13838-0027 Ph: (607) 563-2333 | Benjamin Dental Group 60 Union St Sidney NY 13838-1430 Ph: (607) 563-2333 |
| NPI Number | 1295777688 |
|---|---|
| Provider Enumeration Date | 06/12/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295777688 | NPI | - | NPPES |
| 00575475 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 033878 (New York) | Primary |
News Archive
Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).
Although researchers have been seeking the origins of preterm birth for many years, the causes are still relatively unknown. By studying the electrical activity that causes contractions, researchers at Washington University in St. Louis and their collaborators have developed a multiscale model they believe may aid in predicting preterm birth.
Researchers at Brigham and Women's Hospital have developed a new technique that improves on the current method for assessing whether primary melanoma is likely to recur and spread, following surgical removal.
China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.
The human protein apolipoprotein A-I binding protein inhibits HIV replication by targeting lipid rafts and reducing virus-cell fusion, according to a new study published in the premier American Society for Microbiology journal mBio by researchers from the George Washington University.
› Verified 1 days ago